Silvia Bosello Selected Research

Silvia Bosello Research Topics

Disease

10	Systemic Scleroderma (Systemic Sclerosis) 01/2019 - 08/2005
5	Rheumatoid Arthritis 10/2016 - 07/2008
3	Arthritis (Polyarthritis) 10/2022 - 12/2005
3	Sjogren's Syndrome (Sjogren Syndrome) 10/2022 - 10/2016
3	Heart Failure 07/2020 - 02/2014
3	Fibrosis (Cirrhosis) 01/2019 - 01/2010
2	digital ulcers 10/2022 - 01/2022
2	COVID-19 01/2022 - 01/2021
2	Autoimmune Diseases (Autoimmune Disease) 10/2016 - 08/2011
2	Synovitis 11/2011 - 07/2008
1	Raynaud Disease (Raynaud's Disease) 01/2022
1	Adult-Onset Still's Disease 07/2020
1	Paraneoplastic Syndromes (Paraneoplastic Syndrome) 07/2020
1	Neoplasms (Cancer) 07/2020
1	Breast Neoplasms (Breast Cancer) 07/2020
1	Inflammation (Inflammations) 12/2019
1	Death (Near-Death Experience) 01/2019
1	Bundle-Branch Block (Fascicular Block) 01/2019
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2019
1	Bronchiectasis 01/2019
1	Cardiac Sudden Death (Sudden Cardiac Arrest) 01/2019
1	Pulmonary Arterial Hypertension 01/2019
1	Polymyalgia Rheumatica (Rhizomelic Pseudopolyarthritis) 01/2017
1	Tenosynovitis 01/2017
1	Bursitis (Adhesive Capsulitis) 01/2017
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 10/2016
1	Myocardial Ischemia (Ischemic Heart Diseases) 11/2015
1	Interstitial Lung Diseases (Interstitial Lung Disease) 07/2014
1	Heart Diseases (Heart Disease) 02/2014
1	Pericardial Effusion 02/2014
1	Chest Pain (Chest Pains) 02/2014
1	Sudden Death 02/2014
1	Myositis (Idiopathic Inflammatory Myopathies) 02/2014
1	Necrosis 07/2011
1	Rheumatic Diseases (Rheumatism) 07/2011
1	Diffuse Scleroderma (Progressive Systemic Sclerosis) 01/2010
1	Infections 08/2005
1	Lung Diseases (Lung Disease) 08/2005

Drug/Important Bio-Agent (IBA)

4	Biomarkers (Surrogate Marker)IBA 12/2019 - 08/2005
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2009 - 12/2005
3	AutoantibodiesIBA 01/2022 - 07/2008
3	Interleukin-6 (Interleukin 6)IBA 08/2011 - 08/2005
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022 - 01/2021
2	Antirheumatic Agents (DMARD)IBA 01/2022 - 01/2021
2	EnzymesIBA 01/2019 - 02/2014
1	anti-scl-70 autoantibodiesIBA 10/2022
1	Nuclear Antigens (Extractable Nuclear Antigens)IBA 01/2022
1	IgA receptor (protein B)IBA 01/2022
1	Antinuclear AntibodiesIBA 01/2022
1	SteroidsIBA 01/2022
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 12/2019
1	Matrix Metalloproteinase 1 (Interstitial Collagenase)IBA 01/2019
1	Collagen Type III (Type III Collagen)IBA 01/2019
1	pro-brain natriuretic peptide (1-76)IBA 01/2019
1	procollagen Type III-N-terminal peptide (PIIP)IBA 01/2019
1	Troponin T (Troponin T1)IBA 01/2019
1	Immunoglobulins (Immunoglobulin)IBA 07/2018
1	Benzene (Benzole)IBA 10/2017
1	GlucocorticoidsIBA 01/2017
1	ThymosinIBA 10/2016
1	TroponinIBA 11/2015
1	Imatinib Mesylate (Gleevec)FDA Link 07/2014
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 07/2014
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 02/2014
1	Rituximab (Mabthera)FDA Link 08/2011
1	CytokinesIBA 08/2011
1	CollagenIBA 08/2011
1	Methotrexate (Mexate)FDA LinkGeneric 07/2011
1	Endothelin Receptors (Endothelin Receptor)IBA 06/2009
1	Vasodilator Agents (Vasodilators)IBA 06/2009
1	B-Cell Activating FactorIBA 07/2008

Therapy/Procedure

6	Therapeutics 07/2020 - 12/2005
1	Adjuvant Radiotherapy 07/2020
1	Radiotherapy 07/2020
1	Immunotherapy 12/2019
1	Traction 01/2019